Liothyronine Sodium Tablets — Class II drug recall D-1344-2014
Terminated recall by SigmaPharm Laboratories LLC, reported 2014-05-28, distributed nationwide. Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalle
| Recall number | D-1344-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SigmaPharm Laboratories LLC, Bensalem, PA, United States |
| Recall initiated | 2014-04-22 |
| Classified | 2014-05-21 |
| Reported by FDA | 2014-05-28 |
| Terminated | 2015-03-16 |
| Distributed | Nationwide (US) |
| Quantity | 43,007 bottles |
| NDC | 42794-0018, 42794-0018-02, 42794-0018-06, 42794-0018-12, 42794-0019, 42794-0019-02, 42794-0019-06, 42794-0019-12, 42794-0020, 42794-0020-02, 42794-0020-12 |
| Expiration dates | 2015-01, 2015-03, 2015-10 |
Product
Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.
Reason for recall
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1344-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.